Alto Neuroscience Inc.

ANRO | NYSE

Price Alert Chart Builder DCF Calculator

$30.63

+$0.36 (+1.19%)

At close: Sep 21, 2026, 4:00 PM ET

$30.95

+$0.32 (+1.04%)

Pre-market: Sep 22, 2026, 4:52 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.07B

Enterprise Value $838.24M

Beta 1.16

Average Volume 477.35K

Shares Outstanding (Diluted) 42.81M

Shares Change YoY 58.14%

Institutional Ownership 81.57%

Exchange NYSE

ISIN US02157Q1094

Price Performance

Price Change 1M -11.5%

Price Change 3M 25.3%

Price Change 6M 48.2%

Price Change YTD 84.6%

Price Change 1Y 669.6%

Price Change 3Y 48.0%

Price Change 5Y 48.0%

1M CAGR (ann.) 6.8%

1Y CAGR (ann.) 645.3%

5Y CAGR (ann.) N/A

All-Time CAGR 16.0%

Valuation

PE Ratio -12.35

Forward PE N/A

PEG Ratio 2.50

Forward PEG -1.21

PS Ratio N/A

Forward PS N/A

PB Ratio 4.90

P/FCF Ratio -15.61

P/Adj. FCF Ratio -13.89

P/OCF Ratio -19.26

EV/Sales N/A

EV/EBIT -10.23

EV/EBITDA -10.29

EV/FCF -12.18

Earnings Yield -8.1%

FCF Yield -6.4%

Adj. FCF Yield -7.2%

Financial Health

Net Cash $236.68M

Total Debt $7.05M

Cash & Short-Term Investments $243.73M

Total Assets $254.07M

Current Ratio 14.85

Quick Ratio 14.85

Debt / Equity Ratio 0.03

Debt / EBITDA -0.09

Debt / FCF -0.10

OCF / Debt -9.69

Interest Coverage 19.66

Altman Z-Score 17.14

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -12.4%

Returns

Return on Assets -33.2%

Return on Equity -46.5%

Return on Invested Capital 18.4%

Return on Capital Employed 18.7%

Return on Tangible Assets -33.2%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -14.1%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -23.1%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 9

EPS Growth Next 3Y -7.0%

Revenue Growth Next 3Y N/A

Earnings Date Nov 10, 2026

EPS Estimate (next Q) -$0.67

EPS Growth Est (next Q) 29.4%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $38

Price Target Upside 24.1%

Cash Flow

Operating Cash Flow $-68.29M

Free Cash Flow $-68.84M

Adj. Free Cash Flow $-77.41M

FCF Per Share -$1.61

OCF Per Share -$1.59

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-184K

Operating Income $44.46M

EBITDA $-81.47M

Net Income $-84.24M

EPS (Diluted) -$2.48

Revenue / Employee N/A

Profit / Employee $-1.24M

Employees 68